Related Experiment Video
Updated: Dec 30, 2025
12:18
Assembly of Cell Mimicking Supported and Suspended Lipid Bilayer Models for the Study of Molecular Interactions
Published on: August 3, 2021
4.0K
Molecular Assemblies of Biomimetic Microcapsules
1Beijing National Laboratory for Molecular Sciences, CAS Key Lab of Colloid, Interface and Chemical Thermodynamics , Institute of Chemistry, Chinese Academy of Sciences , Beijing , 100190 , China.
Langmuir : the ACS Journal of Surfaces and Colloids
|February 15, 2019
Summary
Researchers developed stable, autofluorescent, pH-sensitive microcapsules using Schiff base covalent assembly. These biomimetic microcapsules show promise as advanced drug carriers.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Layer-by-layer (LbL) assembly is a versatile technique for microcapsule fabrication.
- Various interactions like electrostatic and hydrogen bonding are used in LbL assembly.
- Schiff base bonds offer enhanced stability and unique properties like autofluorescence and pH sensitivity.
Purpose of the Study:
- To construct biomimetic microcapsules utilizing Schiff base mediated LbL assembly.
- To investigate the structural and property characteristics of these novel microcapsules.
- To highlight the potential applications of these microcapsules as drug delivery vehicles.
Main Methods:
- Employing Schiff base chemistry for covalent cross-linking within the LbL assembly process.
- Fabricating microcapsules with controlled layer-by-layer deposition.
- Characterizing the structure and properties, including autofluorescence and pH responsiveness.
Main Results:
- Successfully constructed biomimetic microcapsules via Schiff base mediated LbL assembly.
- Demonstrated enhanced stability and inherent autofluorescence of the assembled microcapsules.
- Confirmed pH sensitivity, indicating potential for controlled release applications.
Conclusions:
- Schiff base mediated LbL assembly provides a robust method for creating advanced microcapsules.
- The developed microcapsules possess desirable properties for drug delivery systems.
- These biomimetic microcapsules represent a promising platform for future therapeutic applications.
